<!DOCTYPE html>
<html>
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Apple macOS version 5.8.0">
<meta http-equiv="Content-Type" content=
"text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:"Calibri Light";
        panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:0cm;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
h1
        {mso-style-link:"Heading 1 Char";
        margin-top:12.0pt;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:0cm;
        line-height:107%;
        page-break-after:avoid;
        font-size:16.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;
        font-weight:normal;}
h3
        {mso-style-link:"Heading 3 Char";
        margin-top:2.0pt;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:0cm;
        line-height:107%;
        page-break-after:avoid;
        font-size:12.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;
        font-weight:normal;}
a:link, span.MsoHyperlink
        {color:#0563C1;
        text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-link:"Heading 1";
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;}
span.Heading3Char
        {mso-style-name:"Heading 3 Char";
        mso-style-link:"Heading 3";
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;}
.MsoChpDefault
        {font-family:"Calibri",sans-serif;}
.MsoPapDefault
        {margin-bottom:8.0pt;
        line-height:107%;}
@page WordSection1
        {size:595.3pt 841.9pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
 /* List Definitions */
 ol
        {margin-bottom:0cm;}
ul
        {margin-bottom:0cm;}
-->
</style>
<title></title>
</head>
<body lang="EN-AU" link="#0563C1" vlink="#954F72" style=
'word-wrap:break-word'>
<div class="WordSection1">
<h1><span lang="EN-GB" style=
'font-size:14.0pt;line-height:107%'>2020B09</span> <span lang=
"EN-GB">Discuss factors that influence the toxicity of local
anaesthetics<br>
when used for topical anaesthesia of skin and mucosa.</span></h1>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<h3><span lang="EN-GB">List:</span></h3>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;text-indent:-13.5pt'>
<span lang="EN-GB" style=
'font-size:10.0pt;line-height:107%;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt;line-height:107%'>Means
of toxicity</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;text-indent:-13.5pt'>
<span lang="EN-GB" style=
'font-size:10.0pt;line-height:107%;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt;line-height:107%'>Determinants of drug
uptake</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;text-indent:-13.5pt'>
<span lang="EN-GB" style=
'font-size:10.0pt;line-height:107%;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt;line-height:107%'>Determinants of LAST
susceptibility</span></p>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<h3><span lang="EN-GB">Means of toxicity:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'>LAST</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Systemic blockade of
voltage-gated Na+ channels (</span><span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Cambria Math",serif'>&acirc;&circ;</span>
<span lang="EN-GB" style='font-size:10.0pt'>dose)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CNS effects: e.g.
seizure, coma</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CVS effects: e.g.
arrhythmia, arrest</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'>Cocaine
toxicity</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Effects mostly</span>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Cambria Math",serif'>&acirc;&circ;</span>
<span lang="EN-GB" style='font-size:10.0pt'>dose</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Effects ? additive ?
synergistic with other local anesthetics (e.g. nasal
surgery)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CVS:
&acirc;&dagger;&OpenCurlyQuote;&acirc;&dagger;&OpenCurlyQuote;noradrenaline
-&gt; &acirc;&dagger;&OpenCurlyQuote;BP,
&acirc;&dagger;&OpenCurlyQuote;HR, coronary vasoconstriction,<br>
Cardiomyopathy (? idiosyncratic)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CNS:
&acirc;&dagger;&OpenCurlyQuote;&acirc;&dagger;&OpenCurlyQuote;dopamine
-&gt; euphoria, risk-taking</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Nasal: profound
vasoconstriction -&gt; ischaemic necrosis (</span><span lang=
"EN-GB" style=
'font-size:10.0pt; font-family:"Cambria Math",serif'>&acirc;&circ;</span>
<span lang="EN-GB" style='font-size: 10.0pt'>dose)</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'>Prilocaine
toxicity</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;Methaemoglobin
-&gt; Hb unable to bind O<sub>2</sub> (</span><span lang="EN-GB"
style=
'font-size:10.0pt;font-family:"Cambria Math",serif'>&acirc;&circ;</span>
<span lang="EN-GB" style='font-size:10.0pt'>dose)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;&acirc;&dagger;&OpenCurlyQuote;Risk
of reductase deficiency: neonate, congenital</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>Hypersensitivity</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>i.e. allergy,
anaphylaxis (dose-independent)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>e.g. PABA metabolite of
esters</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>e.g. sodium
metabisulfite preservative with lignocaine</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<h3><span lang="EN-GB">Determinants of drug uptake:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>Diffusion
rate:</span></u></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<i><span lang="EN-GB" style=
'font-size:10.0pt'>Fick&acirc;&euro;&TRADE;s law:</span></i></p>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'><img width="357"
height="67" id="Picture 9" src=
"2020B09_topical_local_anaesthetic_toxicity_files/image001.jpg"></span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp; -
&acirc;&dagger;&OpenCurlyQuote;C<sub>1</sub></span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;Drug
concentration (e.g. 10% lignocaine for airway
topicalisation)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Eutectic mixture:
optimal ratio -&gt; &acirc;&dagger;&OpenCurlyDoubleQuote;melting
point -&gt; liquid state -&gt;
&acirc;&dagger;&OpenCurlyQuote;C<sub>1</sub> (cf.
solution)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>EMLA: 2.5% lignocaine + 2.5%
prilocaine, melting point 18</span><span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&deg;</span><span lang="EN-GB" style=
'font-size:10.0pt'>C</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp; -
&acirc;&dagger;&OpenCurlyDoubleQuote;C<sub>2</sub></span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;Tissue blood flow
-&gt; &acirc;&dagger;&OpenCurlyDoubleQuote;C<sub>2</sub> but also
offset of local effect</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Intrinsic: e.g. lower
flow to foot cf. scalp</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Drug additive:
adrenaline -&gt; &acirc;&dagger;&OpenCurlyDoubleQuote;rate of
absorption (e.g. nasal lignocaine)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Pathology: hypothermia,
shock, heart failure</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp; -
&acirc;&dagger;&OpenCurlyQuote;Area</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraph" style=
'margin-top:0cm;margin-right:0cm;margin-bottom: 0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;Area of
application -&gt; &acirc;&dagger;&OpenCurlyQuote;total absorption
but &acirc;&dagger;&CloseCurlyDoubleQuote; absorption per unit
area</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp; -
&acirc;&dagger;&OpenCurlyDoubleQuote;Thickness</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Extensor thicker than
flexor</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Lower limb thicker than
upper limb</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Mucous membrane -&gt;
&acirc;&dagger;&OpenCurlyDoubleQuote;&acirc;&dagger;&OpenCurlyDoubleQuote;thickness,
&acirc;&dagger;&OpenCurlyQuote;&acirc;&dagger;&OpenCurlyQuote;rate
of blood flow</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Contraindication for EMLA, topical
amethocaine</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Risk of inadvertent overdose
during topicalisation for AFOI</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp; -
&acirc;&dagger;&OpenCurlyQuote;Diffusion</span></p>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt'>&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp;&Acirc;&nbsp;
&Acirc;&nbsp;coefficient</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;Lipid solubility
-(lignocaine 150x, prilocaine 50x procaine)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;%
unionized</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Drug: lignocaine 25%, prilocaine
33%, higher than most</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Additive: NaOH in EMLA -&gt;
&acirc;&dagger;&OpenCurlyQuote;pH</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyDoubleQuote;Molecular
weight (all LA drugs have similar MW 200-250g/mol)</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>Diffusion
time:</span></u></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Uptake</span>
<span lang="EN-GB" style=
'font-family:"Cambria Math",serif;color:#202124;background:white'>&acirc;&circ;</span>
<span lang="EN-GB" style='font-size:10.0pt'>application
time</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>EMLA 30 mins for PIVC,
120 mins for skin graft</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>2% lignocaine viscous
gargle &lt; 1 minute for pharyngeal topicalisation</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<h3><span lang="EN-GB">Determinants of LAST
susceptibility:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'>Drug</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>Pharmacokinetics
(PK):</span></u></p>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Esters: rapid
metabolism by BChE -&gt; short
t<sub>1/2</sub></span><sub><span lang="EN-GB" style=
'font-size:10.0pt'>&Icirc;&sup2;</span></sub></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Amides: slow metabolism
by liver -&gt; long t<sub>1/2</sub></span><sub><span lang="EN-GB"
style='font-size:10.0pt'>&Icirc;&sup2;</span></sub></p>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>Pharmacodynamics
(PD):</span></u></p>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Toxicity threshold:
bupiv 1.5mcg/mL, ropiv 4mcg/mL, lignocaine 5mcg/mL</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CC:CNS ratio
&acirc;&euro;&OpenCurlyDoubleQuote; bupivacaine 3:1, ropivacaine
5:1, lignocaine 7:1</span></p>
</td>
</tr>
<tr>
<td width="113" valign="top" style=
'width:84.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<span lang="EN-GB" style='font-size:10.0pt'>Patient</span></p>
</td>
<td width="488" valign="top" style=
'width:366.15pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>PK:</span></u></p>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Absorption: see
above</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Distribution: Cachexia
-&gt; &acirc;&dagger;&OpenCurlyQuote;plasma concentration -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Metabolism: liver
disease -&gt; &acirc;&dagger;&OpenCurlyDoubleQuote;rate of amide
removal -&gt; &acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoNormal" style='margin-bottom:0cm;line-height:normal'>
<u><span lang="EN-GB" style='font-size:10.0pt'>PD:</span></u></p>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>Class 1 antiarrhythmics
-&gt; &acirc;&dagger;&OpenCurlyQuote;Na<sup>+</sup> channel
blockade -&gt; &acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CVS</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;HR
-&gt; &acirc;&dagger;&OpenCurlyQuote;channel cycling rate -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyDoubleQuote;PaO<sub>2</sub>,
&acirc;&dagger;&OpenCurlyDoubleQuote;pH,
&acirc;&dagger;&OpenCurlyQuote;K<sup>+</sup> -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>IHD, channelopathy -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk arrhythmias</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>AV conduction delay -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk high grade block from
lignocaine</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.9pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:Symbol'>&Acirc;&CenterDot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-GB" style='font-size:10.0pt'>CNS</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style=
'font-size:10.0pt'>&acirc;&dagger;&OpenCurlyQuote;PaCO<sub>2</sub>
(&acirc;&dagger;&OpenCurlyQuote;CBF),
&acirc;&dagger;&OpenCurlyDoubleQuote;PaO<sub>2</sub>,
&acirc;&dagger;&OpenCurlyDoubleQuote;pH -&gt;
&acirc;&dagger;&OpenCurlyQuote;risk</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Pregnancy -&gt;
&acirc;&dagger;&OpenCurlyQuote;local anaesthetic
sensitivity</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:35.4pt;text-indent:-9.0pt;line-height:normal'>
<span lang="EN-GB" style=
'font-size:10.0pt;font-family:"Courier New"'>o </span><span lang=
"EN-GB" style='font-size:10.0pt'>Epilepsy, tramadol -&gt;
&acirc;&dagger;&OpenCurlyDoubleQuote;seizure threshold</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>Feedback welcome
at</span> <span lang="EN-GB"><a href=
"mailto:ketaminenightmares@gmail.com"><span style=
'font-size:10.0pt; line-height:107%'>ketaminenightmares@gmail.com</span></a></span></p>
<p class="MsoNormal" style='margin-bottom:0cm'><span lang="EN-GB"
style='font-size: 10.0pt;line-height:107%'>&nbsp;</span></p>
</div>
</body>
</html>
